HIV / AIDS

The method uses genetic sequencing to pinpoint the source of new infections following a community intervention, therefore measuring the impact of the intervention.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

New research shows that incidences of suicidality were higher among patients who were prescribed EFV compared to a control group; the results indicate that EFV, rather that treatment initiation timelines, were correlated with suicidal behavior.

Science doesn’t support legal punishment of HIV-positive people.

A new CDC analysis underscores the need for HIV testing programs in the southern part of the United States to improve linkage medical care among HIV-positive black men who have sex with men (MSM).

OSA is largely untreated in HIV patients, and this lack of treatment likely contributes to further comorbidity complications associated with the virus.

Eradication of HCV in patients with HIV results in reduction of CD4+ and CD8+ T cell immune activation.

At week 96, 73.1% of patients infected with HIV-1 and treated with once-daily doravirine + other ART medications, achieved viral suppression.

Investigators report results of the first randomized clinical trial to test a novel strategy to wake up and kill dormant HIV hiding in reservoir cells.

Dolutegravir and lamivudine combination regimen met primary endpoint in 2 phase 3 studies of treatment-naïve patients with HIV.

Mosaic-based vaccine regimen maintained humoral and cellular HIV immune responses according to long-term data from APPROACH.

New guidelines on the prevention and treatment of HIV in adults from the IAS-USA Panel highlight advances made since the 2016 guidelines, as well as the need for new strategies.

PARTNER 2 study reports zero HIV transmissions over 8 years in gay couples who did not use condoms and had achieved an undetectable viral load on HIV treatment.

More information continues to come to light on the impact of protease inhibitors on patients with HIV and cardiovascular disease.

A new study reports that PrEP users were more likely to receive more primary health care services compared with non-PrEP users.

The FDA has approved the first complete, darunavir-based single-tablet regimen (STR) for the treatment of HIV in treatment-naïve and certain virologically suppressed adults.

In case you missed them, we’ve compiled the top 5 infectious disease articles from this past week.

New research confirms that substance use and certain sexual practices among men who have sex with men may alter gut flora in ways that can have health consequences.

An experimental HIV-1 vaccine regimen reportedly produced immune responses against HIV in humans and rhesus monkeys.

Text messaging is an easy way to improve medication adherence rates, but success depends on a number of factors including youth and race.

Increased testing and education, as well as assistance in financing the cost of care, are clearly needed.

New research finds patients with HIV living in 5 southern states had lower rates of viral suppression and linkage to care compared to people in northern states.

Suicide is a major problem for many patients with infectious diseases but pinpointing the exact cause has proven difficult.

A collection of survey data from 2006 through 2016 found that on average, higher-risk individuals get tested for HIV every 1.4 years.

Skin and soft tissue infections appear to be on the decline in the general population, but individuals with HIV have a higher risk.

Early diagnosis and treatment were essential to ensuring a good prognosis.

In case you missed them, we've compiled the top 5 articles from this past week.

Study results appear to indicate that conceiving while on ART poses a greater risk of stillbirth and miscarriage; however, further analysis revealed a lack of association between ART & poor outcomes.

Implants are promising for long-term, sustained, and reversible delivery of ARV drugs that may bypass adherence challenges for end users.

ViiV Healthcare study results suggest a 2-drug regimen may control HIV in treatment-naïve patients.